You must subscribe to access archives older
than one year.
Take a free trial of Briefing In Play® now.
Subscribe Here
TERMS OF USE

The Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by these Terms of Use. If you do not agree to the terms and conditions contained in these Terms of Use, we do not consent to provide you with an RSS feed and you should not make use of Briefing.com’s RSS service. The use of the RSS service is also subject to the terms and conditions of the Briefing.com Reader Agreement which governs the use of Briefing.com's entire web site (www.briefing.com) including all information services. These Terms of Use and the Briefing.com Reader Agreement may be changed by Briefing.com at any time without notice.

Use of RSS Feeds:
The Briefing.com RSS service is provided free of charge for use by individuals, as long as the feeds are used for such individual’s personal, non-commercial use. Any other uses, including without limitation the incorporation of advertising into or the placement of advertising associated with or targeted towards the RSS Content, are strictly prohibited. You are required to use the RSS feeds as provided by Briefing.com and you may not edit or modify the text, content or links supplied by Briefing.com. To acquire more extensive licensing rights to Briefing.com content please review this page.

Link to Content Pages:
The RSS service may be used only with those platforms from which a functional link is made available that, when accessed, takes the viewer directly to the display of the full article on the Briefing.com web site. You may not display the RSS content in a manner that does not permit successful linking to, redirection to or delivery of the applicable Briefing.com web site page. You may not insert any intermediate page, “splash” page or any other content between the RSS link and the applicable Briefing.com web site page.

Ownership/Attribution:
Briefing.com retains all ownership and other rights in the RSS content, and any and all Briefing.com logos and trademarks used in connection with the RSS service. You are required to provide appropriate attribution to the Briefing.com web site in connection with your use of the RSS feeds. If you provide this attribution using a graphic we require you to use the Briefing.com web site logo that we have incorporated into the Briefing.com RSS feed.

Right to Discontinue Feeds:
Briefing.com reserves the right to discontinue providing any or all of the RSS feeds at any time and to require you to cease displaying, distributing or otherwise using any or all of the RSS feeds for any reason including, without limitation, your violation of any provision of these Terms of Use or the terms and conditions of the Briefing.com Reader Agreement. Briefing.com assumes no liability for any of your activities in connection with the RSS feeds or for your use of the RSS feeds in connection with your web site.

Briefing.com
Subscribers Log In
 
  • HOME
  • OUR VIEW
    • Page One
    • The Big Picture
    • Ahead of the Curve
  • ANALYSIS
    • Premium Analysis
    • Story Stocks
  • MARKETS
    • Stock Market Update
    • Bond Market Update
    • Market Internals
    • After Hours Report
    • Weekly Wrap
  • CALENDARS
    • Upgrades/Downgrades
    • Economic
    • Stock Splits
    • IPO
    • Earnings
    • Conference Calls
    • Earnings Guidance
  • EMAILS
    • Edit My Profile
  • LEARNING CENTER
    • About Briefing.com
    • Ask An Analyst
    • Analysis
    • General Concepts
    • Strategies
    • Resources
    • Video
  • COMMUNITY
    • Twitter
    • Facebook
    • LinkedIn
    • YouTube
    • RSS
  • SEARCH
Login | Archive | EmailEmail |
HOME > Our View >Page One >Hoping to Avoid a Relapse
Page One Archive
Last Update: 20-Jul-11 08:59 ET
Hoping to Avoid a Relapse

A sickly market got a double dose of medicine yesterday that restored its energy.  Both the Dow and S&P 500 gained 1.6%, but it was the Nasdaq that sprinted out of the ICU with a 2.2% gain. 

IBM's solid earnings report and outlook put a bid in things early and then the bids kept coming following reports a bipartisan Senate panel had drafted a deficit reduction plan that just might fly, enabling the U.S. to meet the August 2 deadline for raising the debt ceiling.

Nothing has been set in stone yet on the aforementioned plan.  In fact, a House vote yesterday  in favor of a "cut, cap and balance" plan, which isn't expected to pass the Senate and would be vetoed by the president if it did, has underscored the divisive nature of the debt ceiling negotiation process.

Nonetheless, the equity market at this time is wanting to believe in the possibility at least that the proverbial eleventh-hour solution will be reached.  The overhanging question is, will an eleventh-hour solution be a combo deal where the debt ceiling is raised and a meaningful deficit reduction plan is agreed to or will it simply be a one-dimensional plan to raise the debt limit?

The answer to the last question will matter for the ratings agencies and the market, which is hoping not to be saddled with the realization that everything and nothing got settled at the same time.

The same can be said for the EU debt crisis.   German Chancellor Merkel has indicated, however, that one shouldn't expect a complete solution out of tomorrow's summit, so the issue there is what solution, if any, EU leaders can get out the door for Greece that mitigates concerns about contagion risk being amplified in the near future.

As we noted on Monday, the market's prognosis is day-to-day right now and a chance of relapse is still high given the potential for policy error on either side of the Atlantic.

Fortunately, earnings have been a distracting factor in a good way.  That was demonstrated yesterday by a litany of better-than-expected results and it is being demonstrated again today by another long list of positive surprises.

Apple (AAPL) is clearly at the top of the list, surpassing the Capital IQ consensus estimate by $1.95 and reporting its best quarter ever.  It does not matter that Apple's guidance was "conservative."  That is Apple just being Apple and the market knows that. 

Shares of AAPL are trading 5% higher in pre-market action, which should give the Nasdaq an outperformance edge once again.

Other notables besting estimates include CSX Corp. (CSX), United Technologies (UTX), Cintas (CTAS), Johnson Controls (JCI), and BlackRock (BLK).

What should not be overlooked either on the reporting front is that many of the surprises have been top-line driven.  Looking just at the companies named above, UTX was the "laggard," with revenues up 9.2% year-over-year.  The remaining companies all saw double-digit revenue increases.

The good earnings news has provided an important measure of support for the market as key policy decisions remain in a state of flux.  The S&P futures are 0.4% above fair value at this time. 

As a reminder, the Existing Home Sales report for June (Briefing.com consensus 4.93 mln; prior 4.81 mln) will be released at 10:00 a.m. ET.

--Patrick J. O'Hare, Briefing.com

Patrick J. O'Hare is the Chief Market Analyst for Briefing Research, Briefing.com's institutional research service. To request a free trial please email researchsales@briefing.com.

A sickly market got a double dose of medicine yesterday that restored its energy. Both the Dow and S&P 500 gained 1.6%, but it was the Nasdaq that
 
Add this to my Page Alerts.
MARKET PLACE
SPONSORED LINKS
 
  Follow Us On Linkedin  
 
 
LOGIN

CONTACT US
Support
Sitemap
PREMIUM SERVICES
Take a Tour
Compare Services

INSTITUTIONAL SALES
ADVERTISING

CONTENT LICENSING

EMAILS & NEWSLETTERS
ABOUT US
Our Experts
Management Team

COMMUNITY
MEDIA
Events
News
Awards
PRIVACY STATEMENT
Reader Agreement
Policies
Disclaimer
Copyright © Briefing.com, Inc. All rights reserved.
Close
You must log in or register to access this area.
Virtual Url Page Popup